MUC16 and pancreatic intraductal papillary-mucinous neoplasm: Therefore, CA19-9 can be centrally measured to predict IPMN malignancy in clinical practice, but it is important to take the elevation of CA125 (cut-off value = 13.4 U/ml) into consideration.